Biocon Limited Max Pain Analysis
What is Max Pain?
Max Pain theory states the underlying gravitates toward the strike where option writers face minimum collective loss at expiry. For BIOCON, that strike is ₹340. Spot at ₹350.7 is 3.15% above max pain — possible downward gravitational pull into expiry.
Max Pain Level
The options market’s max‑pain strike for Biocon Limited sits at ₹340, the price at which the combined value of open call and put contracts would cause the greatest loss for option writers. As expiry approaches, the underlying price tends to gravitate toward this level, creating a magnetic effect that can influence trading activity.
Spot vs Max Pain Gap
The current spot price of ₹350.7 sits about 3.15 % above the max‑pain level, indicating a modest premium to the equilibrium point. If the market pulls back toward ₹340, call‑writers stand to profit while put‑writers may see their positions tighten.
Shift Signal
The max‑pain figure moved down 15 points from the previous day, a downward shift that suggests writers are increasingly positioned for a lower underlying price. This positioning could intensify pressure on the spot if sellers aim to drive the price nearer to the new pain zone.
Expiry Context
Max pain reflects the strike where the total open interest of calls and puts would expire worthless, minimizing the aggregate loss for option writers. While historical patterns often show the spot price edging toward this strike during the final week, it remains a statistical tendency rather than a deterministic outcome.
Data Note
Biocon trades roughly ₹10.7 above the max‑pain level with 26 days remaining until the November 23 expiration.
Data as of 2026-10-28